Reported Reactions

Adverse event reports that FDA received

  • Search
  • Watch list

October 2023 adverse event reports that FDA received in the month

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on . The data have the reports that FDA received through .

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.

Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on .

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports received

In October 2023, FDA received 115,632 drug adverse event reports. In October 2022, FDA received 131,961.

In October 2023, FDA received 195,382 medical device reports. In October 2022, FDA received 183,142.

By drug reports received, October 2023 was number 5 of the 12 months of 2023. FDA received 119,835 drug reports a month on average in the 12 months before October 2023.

Receive date

A month is the month in which FDA first received the report, not the month of the event. A report about an event of an earlier year is in the month in which it came to FDA.

Data version

FAERS release of 29 Oct 2026. MAUDE release of 23 Oct 2026.

Drug reports, three years

Drug reports that FDA received each month, 36 months to October 2023
0100,000200,000202120222023

Drugs in the reports

The table has the 146 drug pages with 250 or more reports in October 2023. The rows are in order of name. A drug page with fewer reports is not in the table.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Drugs that the reports of October 2023 name as a suspect product, in order of name
DrugReports in the month
Acetaminophen783
Acetaminophen and codeine966
Acetaminophen Hydrocodone Bitartrate4,812
Acetaminophen Oxycodone Hydrochloride5,191
Actemra308
Adalimumab681
Addyi327
Advil Dual Action With Acetaminophen496
Aimovig525
Albuterol sulfate746
Ambrisentan308
Amlodipine305
Apixaban270
Aspirin382
Atorvastatin501
Avastin286
Belbuca305
Bevacizumab424
Bortezomib374
Buprenorphine hydrochloride523
Butalbital Acetaminophen and Caffeine with Codeine Phosphate251
Calquence274
Capecitabine288
Carbidopa levodopa319
Carboplatin900
Certolizumab pegol338
Cimzia340
Ciprofloxacin295
Cisplatin414
Clozapine1,178
Clozaril263
Cosentyx1,288
Cyclophosphamide1,097
Cyclosporine322
Cytarabine361
Defitelio423
Depodur286
Dexamethasone1,084
Docetaxel359
Doxorubicin476
Dupixent6,087
Eligard677
Eliquis1,137
Enbrel842
Endocet2,038
Endodan292
Entresto1,288
Etoposide413
Farxiga335
Fentanyl citrate910
Fluorouracil413
Folic acid257
Furosemide366
Gabapentin449
Genotropin699
Humira1,941
Hydrocodone bitartrate and acetaminophen412
Hydrocodone Bitartrate Ibuprofen708
Hyrimoz264
Ibrance499
Ibuprofen565
Imbruvica448
Imfinzi302
Inflectra275
Infliximab343
Jakafi367
Jardiance439
Kesimpta857
Keytruda953
Kisqali475
Lamotrigine270
Lantus Solostar263
Leflunomide362
Lenalidomide859
Lenvatinib264
Lenvima400
Letrozole262
Levetiracetam368
Metformin438
Methotrexate1,605
Methotrexate sodium610
Methylprednisolone300
Mirena366
Morphine sulfate1,381
Mounjaro1,674
Mycophenolate mofetil489
Neulasta527
Nucala302
Nuplazid371
Ocrevus532
Ofev286
Olanzapine386
Omeprazole258
Opana853
Opana Er963
Opdivo337
Opsumit272
Orencia808
Otezla385
Oxaliplatin512
Oxycodone398
Oxycodone hydrochloride959
Oxymorphone hydrochloride1,222
Ozempic308
Paclitaxel661
Paxlovid1,169
Pembrolizumab570
Percocet5,010
Pluvicto395
Pomalyst522
Prednisolone481
Prednisone1,401
Pregabalin298
Prolia529
Promethazine hydrochloride and codeine phosphate745
Propoxyphene Hydrochloride598
Quetiapine395
Ranitidine hydrochloride261
Remicade507
Repatha2,174
Revlimid1,387
Rinvoq1,084
Risperidone263
Rituximab1,354
Sertraline278
Simponi477
Skyrizi960
Soliris268
Stelara661
Sublocade351
Sulfasalazine286
Tacrolimus610
Tagrisso383
Taltz309
Tramadol510
Tramadol hydrochloride2,237
Trastuzumab263
Trelegy Ellipta344
Tremfya419
Trulicity541
Tysabri306
Vedolizumab701
Venclexta407
Vincristine396
Xeljanz914
Xywav428

Reaction terms in the reports

The table has the 132 reaction terms with 500 or more reports in October 2023. The rows are in order of name. One report can record more than one term.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Reaction terms that the drug reports of October 2023 record, in order of name
Reaction term (MedDRA) and plain meaningReports in the month
Abdominal discomfortstomach discomfort868
Abdominal painstomach or belly pain1,113
Abdominal pain upperupper stomach pain918
Accidental exposure to product1,160
Acute kidney injurysudden loss of kidney function942
Alopeciahair loss761
Anaemialow red blood cells881
Anxietyanxiety1,235
Arthralgiajoint pain2,421
Astheniaweakness or lack of energy1,845
Asthmaasthma1,622
Atrial fibrillationan irregular heart rhythm533
Back painback pain1,131
Blood glucose increasedraised blood sugar reading611
Blood pressure increaseda raised blood pressure reading691
Cardiac disorder702
Cerebrovascular accidentstroke628
Chest discomfortchest discomfort508
Chest painchest pain726
Chillschills or shivering579
Condition aggravatedthe condition being treated got worse1,851
Confusional stateconfusion719
Constipationconstipation1,126
Coughcough1,679
Covid-19COVID-19 infection2,569
Deaththe patient died; cause not stated by this term5,828
Decreased appetitereduced appetite1,263
Dehydrationdehydration513
Dependence10,389
Depressionlow mood1,476
Developmental delayslower development in a child1,066
Device difficult to usethe device was hard to use1,317
Device issuea problem with the device528
Diarrhoealoose or frequent stools3,379
Disease progressionthe disease advanced870
Disease recurrencethe disease came back723
Disturbance in attentiondifficulty concentrating673
Dizzinesslight-headedness or unsteadiness2,211
Drug dependencedependence on a medicine1,057
Drug dose omission by device2,176
Drug effective for unapproved indication587
Drug hypersensitivityan allergic-type reaction (the term names a medicine)857
Drug ineffectivethe medicine did not work as expected6,529
Drug interactionan interaction between medicines705
Drug intolerancethe medicine was not tolerated577
Drug withdrawal syndrome neonatal2,674
Dry skindry skin725
Dysphagiadifficulty swallowing1,698
Dyspnoeashortness of breath2,934
Eczemaeczema621
Emotional distressemotional distress596
Erythemaskin redness925
Falla fall1,608
Fatiguetiredness3,836
Feeling abnormalfeeling odd or not right950
Foetal exposure during pregnancythe unborn baby was exposed to the medicine3,038
Gait disturbancedifficulty walking1,299
Gait inability532
Gastrointestinal disorder1,432
Gastrooesophageal reflux diseaseacid reflux1,027
General physical health deteriorationgeneral decline in health613
Headachehead pain2,738
Hospitalisationadmission to hospital1,298
Hyperhidrosisexcessive sweating606
Hypersensitivityan allergic-type reaction843
Hypertensionhigh blood pressure1,098
Hypoacusisreduced hearing703
Hypoaesthesianumbness676
Hypotensionlow blood pressure1,139
Ill-defined disordera condition that was not clearly described1,030
Illness1,249
Inappropriate schedule of product administrationthe product was taken at the wrong times1,641
Incorrect dose administeredthe wrong dose was given1,515
Infectionan infection, type not specified855
Influenzaflu580
Injection site erythemaredness where the injection was given508
Injection site painpain where the injection was given1,716
Insomniadifficulty sleeping1,081
Intentional overdosea deliberate overdose534
Intentional product use issuedeliberate use not as intended543
Joint swellinga swollen joint598
Loss of consciousnesspassing out603
Malaisegeneral feeling of being unwell1,866
Malignant neoplasm progression672
Maternal exposure during pregnancythe mother took the medicine during pregnancy672
Memory impairmentmemory problems607
Muscle spasmsmuscle cramps803
Muscular weaknessmuscle weakness507
Myalgiamuscle pain798
Nasopharyngitisa cold1,060
Nauseafeeling sick3,411
Neuropathy peripheralnerve damage in hands or feet568
Neutropenialow neutrophils, a type of white blood cell1,002
No adverse eventno adverse event was reported1,085
Off label useused for a purpose or in a way not on the label6,574
Overdosea dose above the recommended amount4,429
Painpain, site not specified3,129
Pain in extremitypain in an arm or leg1,255
Palpitationsawareness of the heartbeat513
Paraesthesiatingling or pins and needles637
Peripheral swellingswelling of the arms or legs851
Platelet count decreasedlow platelet count613
Pneumonialung infection1,746
Premature babya baby born early662
Product dose omission issuea dose was missed3,050
Product storage errorthe product was stored wrongly998
Product use in unapproved indicationused for a purpose not on the label2,182
Product use issuea problem in how the product was used939
Pruritusitching2,410
Psoriasispsoriasis, a skin condition714
Pyrexiafever1,757
Rashskin rash2,256
Rheumatoid arthritisrheumatoid arthritis, an inflammatory joint disease655
Seizurea fit or convulsion796
Sepsisa severe body-wide response to infection562
Somnolencedrowsiness980
Therapeutic product effect incomplete852
Therapy interrupted812
Thrombocytopenialow platelets642
Toxicity to various agentspoisoning or toxic effect of one or more substances910
Treatment failurethe treatment did not work518
Tremorshaking678
Urinary tract infectionbladder or urinary infection996
Urticariahives809
Vision blurredblurred vision686
Visual impairmentreduced vision1,150
Vomitingbeing sick2,124
Weight decreasedweight loss1,354
Weight increasedweight gain820
White blood cell count decreasedlow white cell count559
Withdrawal syndrome3,510
Wrong technique in product usage processthe product was used in the wrong way1,677

Devices in the reports

The table has the 87 device pages with 250 or more reports in October 2023. The rows are in order of name. A device page with fewer reports is not in the table.

FDA says:

MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices.

Source: openFDA, Manufacturer and User Facility Device Experience. The site read the page on .

Device brand names that the device reports of October 2023 name, in order of name
Brand nameReports in the month
630G Insulin PUMP MMT-1715K 630G BLACK MG359
630G Insulin PUMP MMT-1715KL 630G615
640G Insulin Pump MMT-1712K480
670G Insulin Pump MMT-1780KL1,368
Alaris System6,733
Allura Xper FD320
Biohorizons Dental Implant770
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim395
BLT ?3.3mm NC, SLA? 12mm, TiZr, Loxim281
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP380
BLT ?3.3mm NC, SLActive? 12mm, TiZr, NTP294
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim365
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim571
BLT ?4.1mm RC, SLA? 12mm, TiZr, Loxim294
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim324
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP575
BLT ?4.1mm RC, SLActive? 12mm, TiZr, NTP287
BLT ?4.1mm RC, SLActive? 8mm, TiZr, NTP326
BLT ?4.8mm RC, SLA? 10mm, TiZr, Loxim290
BLT ?4.8mm RC, SLA? 8mm, TiZr, Loxim272
BLT ?4.8mm RC, SLActive? 10mm, TiZr, NTP319
BLT ?4.8mm RC, SLActive? 8mm, TiZr, NTP293
CapSureFix Novus Lead MRI SureScan1,901
CapSureFix Novus MRI SureScan396
Cardiomems Patient Electronic System415
Dexcom G6 Continuous Glucose Monitoring System19,735
Dexcom G7 Continuous Glucose Monitoring System6,135
DreamStation Auto CPAP1,159
Duoderm780
Emblem Mri S-Icd371
Endowrist437
FreeStyle Libre 21,001
FreeStyle Libre 3322
FreeStyle LibreLink323
Guardian Link 3 US362
Hamilton Medical Ag420
HeartWare Ventricular Assist System - Pump641
Impella 5.5848
Implantable Collamer Lens Icl508
Ingevity+306
Inspira Smooth Silicone Gel Filled Breast Implant433
Inspira Textured Silicone Gel Filled Breast Implant325
Intellis609
Libre 2 Sensor FreeStyle1,737
Libre 3 Sensor FreeStyle312
Libre Sensor Freestyle324
LifeVest WCD 4000 System1,368
MENTOR MemoryGel Breast Implant685
MiniMed 770G US System BLE Connect 3.0 mg/dL1,847
MiniMed 780G OUS System BLE Connect 3.0 mmol/L1,181
MiniMed 780G US System BLE Connect 3.0 mg/dL611
NobelActive Internal RP 4.3x10mm593
NobelActive Internal RP 4.3x11.5mm433
NobelActive Internal RP 4.3x13mm306
NobelActive Internal RP 4.3x8.5mm303
NobelActive Internal RP 5.0x10mm261
NobelParallel CC RP 4.3x10mm428
NobelParallel CC RP 4.3x8.5mm250
NobelParallel CC TiUltra RP 4.3x10mm290
NobelReplace CC PMC RP 4.3x10mm319
NobelReplace CC RP 4.3x10mm383
Octrode Lead Kit, 60cm Length383
Omnipod 5 Pod2,071
Omnipod DASH Insulin Management System1,125
Pentax1,044
Perclose Proglide 6f Suture Mediated Closure Smc System312
Perclose ProStyle Suture-Mediated Closure and Repair System746
Proclaim 5 Elite Implantable Pulse Generator299
Pump 1886 780G OUS BLE Pump mg/dL1,174
Pump Mmt-1712kl 640g V4 10 Bk Sf Mg354
Pump MMT-1780KPK 670G Pathway Black MG960
Pump Mmt-1880l Mm770g Ble Mg685
PUMP MMT-1884L MM780G BLE 3.0 mg/ml327
Respironics330
SelectSecure MRI SureScan299
Smartphone Android App: Pump Connect468
Smartphone iOS App: Pump Connect543
Sprint Quattro Secure S MRI SureScan478
Style 68 Saline Filled Breast Implant276
t:slim X2 Insulin Pump with Basal-IQ Technology1,024
t:slim X2 Insulin Pump with Control-IQ Technology14,686
Tendril Sts596
Transmitter Mmt-7841zn Gst5g Us265
Transmitter Mmt-7841zw Gst5g Ous495
Unknown Implant695
Xmtr MMT-7811NA GST3C Lockout256
Xmtr Mmt-7811xww Gst3c Ous280

Cite this page

Reported Reactions. October 2023: adverse event reports received by FDA. https://reportedreactions.com/month/2023-10/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of . Reports received through .

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 29 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Nov 2026. A class is the pharmacologic class (EPC) of the FDA label.

The device counts come from the openFDA Device Adverse Event (MAUDE) bulk files, release of 23 Oct 2026. The files have the reports that FDA received through 30 Sep 2026. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

Can the count for October 2023 change?

Yes. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases. This page has the count of the openFDA release of 29 Oct 2026: 115,632 drug reports.

Does a month with many reports mean that something occurred in that month?

Not by itself. The date is the date on which FDA received the report, not the date of the event. FDA says:

Many factors can influence whether or not an event will be reported, such as the time a product has been marketed and publicity about an event.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

How does a person report an adverse event?

FDA runs MedWatch, a program that takes voluntary reports from health professionals, patients and consumers. The guide on how to report has the links.